Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
MBHB - Massachusetts Institute of Technology focuses on Biotechnology & Pharmaceuticals and has 106 career applications. The profile lists 7 pending office actions and a 72.5% resolved allowance rate, meaning allowance was recorded for a smaller share of resolved applications than non-allowance outcomes.
The average of 4.07 office actions per allowance indicates repeated examination activity among applications that reached allowance. Practitioners should consider the outcome rate and response burden together when evaluating prosecution strategy for this profile.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARTINEZ, TARA L | 1 | 62.7% | +65.6% |
| KARUNASENA, ENUSHA | 1 | 25.0% | +100.0% |
| FAN, WEIHUA | 1 | 83.3% | +12.7% |
| ZHANG, KELING NMN | 1 | 66.8% | +17.6% |
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
| REDDEN, KAREN M | 1 | 88.4% | -21.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690033 | A MICROBIAL ELECTROCHEMICAL TECHNOLOGY TO DETECT AND DEGRADE ORGANOPHOSPHATE PESTICIDES | FAN, WEIHUA | 8d overdue |
| 16865684 | NEXT GENERATION OF LIGHT-EMITTING PLANT LONGER DURATION AND BRIGHTER | REDDEN, KAREN M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907603 | PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC TARGETS IN PLANTS | JANOSKO, CHASITY PAIGE | 30d |
| 17978010 | Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor | ZHANG, KELING NMN | 57d |
| 18770880 | HEME-BINDING SMALL PEPTIDE | MARTINEZ, TARA L | — |
| 18726542 | CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION | KARUNASENA, ENUSHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690033 | A MICROBIAL ELECTROCHEMICAL TECHNOLOGY TO DETECT AND DEGRADE ORGANOPHOSPHATE PESTICIDES | FAN, WEIHUA | 8d overdue |
| 17907603 | PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC TARGETS IN PLANTS | JANOSKO, CHASITY PAIGE | 30d |
| 17978010 | Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor | ZHANG, KELING NMN | 57d |
| 18770880 | HEME-BINDING SMALL PEPTIDE | MARTINEZ, TARA L | — |
| 18726542 | CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION | KARUNASENA, ENUSHA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| MIT | 5 |
| THE GENERAL HOSPITAL CORPORATION | 1 |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1653 | 1 |
| 1663 | 1 |
| 1732 | 1 |
| 1613 | 1 |
| 1661 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18770880 | HEME-BINDING SMALL PEPTIDE | Massachusetts Institute Of Technology | MARTINEZ, TARA L | 1654 | §102§103 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18726542 | CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION | The General Hospital Corporation | KARUNASENA, ENUSHA | 1653 | §102§103§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18690033 | A MICROBIAL ELECTROCHEMICAL TECHNOLOGY TO DETECT AND DEGRADE ORGANOPHOSPHATE PESTICIDES | Massachusetts Institute Of Technology | FAN, WEIHUA | 1663 | §103 | Non-Final OA | 8d overdue | Pending | Mar 07, 2024 |
| 17978010 | Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor | Massachusetts Institute Of Technology | ZHANG, KELING NMN | 1732 | §102§103Other | Final Rejection | 57d | Pending | Oct 31, 2022 |
| 17907603 | PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC TARGETS IN PLANTS | Massachusetts Institute Of Technology | JANOSKO, CHASITY PAIGE | 1613 | §103 | Final Rejection | 30d | Pending | Sep 28, 2022 |
| 16865684 | NEXT GENERATION OF LIGHT-EMITTING PLANT LONGER DURATION AND BRIGHTER | Massachusetts Institute Of Technology | REDDEN, KAREN M | 1661 | §103 | Final Rejection | — | Pending | May 04, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial72.5% of resolved applications prosecuted by Mbhb - Massachusetts Institute Of Technology were allowed, across 106 applications in USPTO records.
4.07 office actions per allowed application on average.
6 pending office actions as of October 2026, for 2 clients, before 6 examiners in 6 art units.
